Fleury Expands Regional Reach with R$39.5 Million Hemolab Acquisition

Fleury, one of Brazil’s leading diagnostic medicine groups, has agreed to purchase Hemolab Medicina Laboratorial for R$39.5 ($7) million, according to an official company statement.

Hemolab operates 15 clinical analysis and pathology units across nine cities in Minas Gerais. Last year, Hemolab reported R$31 million in revenue, reflecting its established presence in the region.

This acquisition marks another step in Fleury’s strategy to expand its footprint through targeted purchases. The company has pursued similar moves in recent years, including the acquisition of Méthodos in southern Minas Gerais.

These figures show that Fleury expects to improve efficiency and profitability by integrating Hemolab’s operations. The company’s CEO, Jeane Tsutsui, stated that the acquisition aligns with Fleury’s financial strength and strategic criteria, including price, cultural fit, and growth potential.

Fleury’s expansion reflects a broader trend in Brazil’s healthcare sector, where large groups consolidate smaller regional players to gain scale and efficiency. This approach allows companies to lower costs, improve service quality, and expand their customer base.

In the case of Fleury, the company’s recent acquisitions have focused on regions with growing demand for diagnostics and a high proportion of residents with health insurance.

Hemolab, with over 30 years of experience, brings local expertise and a reputation for quality service. Fleury’s integration of Hemolab could mean broader access to advanced diagnostics for patients in Minas Gerais. The deal remains subject to regulatory approval.

Fleury’s acquisition strategy has not increased its debt levels, as the company maintains a leverage rate of about 1.2 times net debt. The group continues to invest in technology and organic growth, aiming to strengthen its position as a leading healthcare provider in Brazil’s competitive diagnostics market.

Related coverage: Iron Ore Slips as Supply Rises and Chinese Demand Fails to Impress · Silver Holds Steady as Supply Squeeze and Rate Cut Bets Shape Market · Wilson Sons Sale and Delisting Reflect Brazil’s Changing Business Landscape · Brazil’s Retail Sales Show Mixed Signals in April as Consumer Debt and Job Growth Collide

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.